I'm thinking that if Anteotech is not involved in a test for covid being developed by a collaborator there still exists the huge potential that a poc lateral flow test is being developed to prove immunity in those that have had it and in the future once there has been a vaccine developed.
I think this could be huge for the company and as a few have said if they can't get the tech involved in this on the diagnostic front what can they get it in?
really looking forward to next few announcements from the company
GLTA
Ann: Change of Director's Interest Notice x 4, page-22
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
